Fostair Pink is a prescription inhaler used for treating asthma and severe COPD (Chronic Obstructive Pulmonary Disease) in adults.
Fostair pink inhaler (100/6) contains 100 micrograms of beclometasone dipropionate (inhaled corticosteroid) that prevents symptoms of asthma and 6 micrograms of formoterol fumarate dihydrate (β2—agonist) that dilates the airways to relieve asthma symptoms.
The British National Formulary (BNF) considers Fostair a more potent inhaler than traditional beclometasone-containing inhalers.
The following properties make it a potent inhaler with a rapid onset of action; however, the strength also depends upon the number of puffs inhaled.
The combination of its active ingredients, beclometasone, and formoterol fumarate, makes it a potent inhaler. Beclometasone is a strong inhaled steroid 500-600 times more potent than dexamethasone. Similarly, formoterol fumarate is a potent inhaled beta-agonist 50 times stronger than salbutamol (Ventolin).
Fostair pink (100/6) contains its ingredients in extra fine particles, which means that 100 micrograms of beclometasone in one inhalation of Fostair is almost equal to 250 micrograms of beclometasone in a non-extra fine formulation. That’s why BNF suggests dose adjustments whenever switching to other inhalers.
Fostair pink has a rapid onset of action, providing quick relief of symptoms in 1-3 minutes. These effects usually last up to 12 hours. Formoterol fumarate is a strong beta-agonist that relaxes the smooth muscles of airways, improving airflow and, thus, asthma symptoms.
In addition to the rapid action, Fostair provides prolonged prevention of asthma symptoms. Beclometasone, an active ingredient of Fostair, reduces inflammation in the airway tracts to make breathing easier.
Fostair's strength also depends on the number of puffs taken. Each puff of Fostair pink (100/6) contains 100 micrograms of beclometasone and 6 micrograms of formoterol. So, 4 puffs of Fostair pink will provide about 800 micrograms of beclometasone and 24 micrograms of formoterol.
Steroid-containing inhalers can cause oral thrush and dry or sour throat, which can be managed with proper inhaler techniques and a space device.
However, Fostair can also cause other side effects, such as dizziness, palpitations, headache, flu-like symptoms, blurred vision, and sometimes, tremors. These side effects require urgent medical attention.
According to the NHS, Fostair can be used as a preventer and a reliever for asthma because it prevents further episodes and relieves current asthma symptoms.
Unfortunately, yes, inhaled steroids (such as beclometasone) can cause oral thrush because they weaken the oral immunity against fungal infections. However, the risk of oral thrush can be minimised by rinsing the mouth after using the inhaler and using a spacer device with the inhaler.
Yes. The NICE guidelines 2019 recommends using Fostair Pink 100/6 in adults with severe COPD.
Sources
BNF 2024. Beclometasone with formoterol
ScienceDirect 2023. Beclometasone Dipropionate
NHS 2023. Common questions about beclometasone inhalers
NICE guidelines 2019. What inhaled corticosteroids are available for COPD, and what dose should I prescribe?
Additional Resources
© 2013 - 2024 Al Muhsineen Limited. All Rights Reserved. Registered Pharmacy: 34 Halliwell Road, Bolton BL1 8RL. Registered Office: 254 First Floor, Shearbrow, Blackburn, England, BB1 8DS